AIMS/HYPOTHESIS: Growth factor imbalance and endothelial progenitor cell dysfunction are well-known elements of the inappropriate response to injury in human and experimental diabetes. We hypothesised that in diabetes the outgrowth of myofibroblast progenitor cells (MFPCs) is also altered and that this relates to aberrant gene expression of growth factors involving members of the TGF-beta/bone morphogenetic protein (BMP) superfamily. SUBJECTS AND METHODS: MFPCs were cultured from peripheral blood mononuclear cells of patients with type 1 diabetes and control subjects. Microarray analysis, quantitative PCR and ELISA were used to identify differentially regulated TGF-beta/BMP superfamily genes in diabetes- and control-derived MFPC. Possible effects of BMP6 on TGF-beta-induced gene expression were examined in cultured renal fibroblasts (TK173 cells). RESULTS: Blood from diabetic patients yielded higher numbers of MFPCs than blood from control subjects (1.6-fold increase, p<0.05), involving increased proliferation and decreased apoptosis. BMP6 mRNA and protein were downregulated in MFPCs derived from patients with diabetes (3.9- and 1.8-fold decrease, respectively, p<0.05). Furthermore, an inverse correlation was observed between BMP6 mRNA level and the number of MFPCs in patients with diabetes (r=-0.85, p<0.05). In TK173 cells, BMP6 antagonised the TGF-beta-induced expression of the genes encoding plasminogen activator inhibitor-1 and connective tissue growth factor (70 and 50% reduction, respectively). CONCLUSIONS/ INTERPRETATION: Considering the importance of BMP6 in processes such as angiogenesis and its novel anti-TGF-beta effects, we propose that the excess numbers of BMP6-deficient MFPCs may favour adverse tissue remodelling in patients with diabetes, both numerically and by inappropriate orchestration of their microenvironment.
AIMS/HYPOTHESIS: Growth factor imbalance and endothelial progenitor cell dysfunction are well-known elements of the inappropriate response to injury in human and experimental diabetes. We hypothesised that in diabetes the outgrowth of myofibroblast progenitor cells (MFPCs) is also altered and that this relates to aberrant gene expression of growth factors involving members of the TGF-beta/bone morphogenetic protein (BMP) superfamily. SUBJECTS AND METHODS: MFPCs were cultured from peripheral blood mononuclear cells of patients with type 1 diabetes and control subjects. Microarray analysis, quantitative PCR and ELISA were used to identify differentially regulated TGF-beta/BMP superfamily genes in diabetes- and control-derived MFPC. Possible effects of BMP6 on TGF-beta-induced gene expression were examined in cultured renal fibroblasts (TK173 cells). RESULTS: Blood from diabeticpatients yielded higher numbers of MFPCs than blood from control subjects (1.6-fold increase, p<0.05), involving increased proliferation and decreased apoptosis. BMP6 mRNA and protein were downregulated in MFPCs derived from patients with diabetes (3.9- and 1.8-fold decrease, respectively, p<0.05). Furthermore, an inverse correlation was observed between BMP6 mRNA level and the number of MFPCs in patients with diabetes (r=-0.85, p<0.05). In TK173 cells, BMP6 antagonised the TGF-beta-induced expression of the genes encoding plasminogen activator inhibitor-1 and connective tissue growth factor (70 and 50% reduction, respectively). CONCLUSIONS/ INTERPRETATION: Considering the importance of BMP6 in processes such as angiogenesis and its novel anti-TGF-beta effects, we propose that the excess numbers of BMP6-deficient MFPCs may favour adverse tissue remodelling in patients with diabetes, both numerically and by inappropriate orchestration of their microenvironment.
Authors: P C Grimm; P Nickerson; J Jeffery; R C Savani; J Gough; R M McKenna; E Stern; D N Rush Journal: N Engl J Med Date: 2001-07-12 Impact factor: 91.245
Authors: F Cornacchia; A Fornoni; A R Plati; A Thomas; Y Wang; L Inverardi; L J Striker; G E Striker Journal: J Clin Invest Date: 2001-12 Impact factor: 14.808
Authors: T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner Journal: Science Date: 1997-02-14 Impact factor: 47.728
Authors: Maarten B Rookmaaker; Anke M Smits; Herman Tolboom; Karin Van 't Wout; Anton C Martens; Roel Goldschmeding; Jaap A Joles; Anton Jan Van Zonneveld; Herman-Joseph Gröne; Ton J Rabelink; Marianne C Verhaar Journal: Am J Pathol Date: 2003-08 Impact factor: 4.307
Authors: Song Wang; Qing Chen; Theodore C Simon; Frank Strebeck; Lala Chaudhary; Jeremiah Morrissey; Helen Liapis; Saulo Klahr; Keith A Hruska Journal: Kidney Int Date: 2003-06 Impact factor: 10.612
Authors: Amélie Dendooven; Olivia van Oostrom; Dionne M van der Giezen; Jan Willem Leeuwis; Cristel Snijckers; Jaap A Joles; Elizabeth J Robertson; Marianne C Verhaar; Tri Q Nguyen; Roel Goldschmeding Journal: Am J Pathol Date: 2011-03 Impact factor: 4.307
Authors: Lovorka Grgurevic; Boris Macek; David R Healy; Amy L Brault; Igor Erjavec; Antonio Cipcic; Ivica Grgurevic; Dunja Rogic; Kresimir Galesic; Jelena Brkljacic; Ranka Stern-Padovan; Vishwas M Paralkar; Slobodan Vukicevic Journal: J Am Soc Nephrol Date: 2011-03-17 Impact factor: 10.121